Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06216418
Other study ID # JWD-TH-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 29, 2024
Est. completion date October 30, 2025

Study information

Verified date January 2024
Source Hugel
Contact Cho Long Park
Phone +82-2-6966-1654
Email clpark@hugel.co.kr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluate the Safety and Efficacy of 'BRFS-18G-S100WH' as Compared to 'MINT Lift FINE+' in Subject With Nasolabial Folds.


Description:

This clinical trial was conducted on patients who wanted to improve both nasolabial folds through facial tissue lifting using facial tissue fixing material 'BRFS-18G-S100WH' made of polydioxanone (PDO). Compared to 'MINT Lift FINE+', we want to confirm whether it has a non-inferior temporary wrinkle improvement effect and can be safely applied to the human body.


Recruitment information / eligibility

Status Recruiting
Enrollment 106
Est. completion date October 30, 2025
Est. primary completion date July 31, 2025
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: 1. Adults over 19 years of age 2. Those who wish to temporarily improve nasolabial folds on both sides of the face and have a score of 3 (Moderate) or 4 (Severe) on the WSRS (Wrinkle Severity Rating Scale) 3. Those who voluntarily decided to participate in this clinical trial and agreed to the subject description and consent form in writing Exclusion Criteria: 1. A person who has undergone a procedure using filler or facial tissue fixation thread on the facial area. 2. Those who are pregnant or lactating

Study Design


Related Conditions & MeSH terms


Intervention

Device:
BRFS-18G-S100WH
A facial tissue fixation material made of polydioxanone (PDO).
MINT Lift FINE+
A facial tissue fixation material made of polydioxanone (PDO).

Locations

Country Name City State
Korea, Republic of Hugel Inc. Seoul

Sponsors (2)

Lead Sponsor Collaborator
Hugel Jworld

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement rate (%) at 12 weeks after the procedure compared to baseline. Improvement rate (%) at 12 weeks after the procedure compared to baseline by an independent evaluator. Baseline to week 12
Secondary WSRS evaluation by an independent evaluator Improvement rate (%): 4, 8, and 24 weeks after treatment. Baseline score change (points): 4, 8, 12, and 24 weeks after the procedure. Baseline to week 4, 8, 24
Secondary WSRS evaluation by tester Improvement rate (%): 4, 8, and 24 weeks after treatment. Baseline score change (points): 4, 8, 12, and 24 weeks after the procedure. Baseline to week 4, 8, 24
Secondary Satisfaction level (%) at 4, 8, 12, and 24 weeks after the procedure compared to the baseline. Satisfaction level (%) at 4, 8, 12, and 24 weeks after the procedure compared to the baseline by the subject Baseline to week 4, 8, 12, 24
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06018987 - A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds Phase 2/Phase 3
Completed NCT01115634 - Autologous Fibroblast Transplantation in Facial Deformities Phase 2
Completed NCT01012661 - Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler Phase 4
Completed NCT00778531 - Protocol for the Post-approval Study of ArteFill® for Correction of Nasolabial Folds Phase 4
Completed NCT03932045 - A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds N/A
Completed NCT02647853 - Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers Phase 1
Completed NCT01069354 - Evaluation of Pain With Radiesse® With Lidocaine for Nasolabial Folds N/A
Completed NCT00850889 - Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds Phase 4
Completed NCT00797459 - Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds N/A
Recruiting NCT06093321 - A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement N/A
Not yet recruiting NCT06295172 - A Study Comparing Lafullen15 and Lafullen for Temporary Nasolabial Fold Improvement N/A
Completed NCT01060943 - An Efficacy and Safety Study of TheraFill® Versus KOKEN for 3 Months on Nasolabial Folds Phase 3
Completed NCT05612958 - Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds N/A
Completed NCT02672644 - Non-comparative Evaluation of Facial Expressions Following Lower Face Correction Using Emervel Classic and Emervel Deep Phase 4
Completed NCT01012388 - Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color Phase 4
Completed NCT01635855 - Belotero Post Approval Study Phase 4
Completed NCT02179736 - A Post Market Evaluation After Treatment of Nasolabial Folds N/A
Terminated NCT00716443 - Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections Phase 4
Recruiting NCT02607670 - Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds Phase 2
Completed NCT00823069 - Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose N/A